Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Project
BIOLOPTIM: implementation of therapeutic drug monitoring for biologicals in psoriasis and hidradenitis supparativa
Information
Project Team
Organisations
Outputs & Impact
Publications & research data ( 12 )
Exposure-response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis
Rani Soenen
Lisa Schots
Z. Wang
Laurentijn Tilleman
Filip Van Nieuwerburgh
Lynda Grine
L. Temmerman
T. Hillary
A. Stockman
E. Dreesen
et al.
A1
Journal Article
in
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2024
Ixekizumab trough concentrations in psoriasis : paving the way towards personalised therapy : a cohort study
Lisa Schots
Rani Soenen
Debby Thomas
Annelies Stockman
Erwin Dreesen
Anke Eylenbosch
Jo Lambert
A2
Journal Article
in
JEADV CLINICAL PRACTICE
2024
Blocking interleukin-17 in psoriasis : real-world experience from the PsoPlus cohort
Lisa Schots
Rani Soenen
Brigitte Blanquart
Debby Thomas
Jo Lambert
A1
Journal Article
in
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2023
Therapeutic drug monitoring in psoriasis : from empiric dose adaptations to guided clinical decision making
Rani Soenen
Jo Lambert
Paul Declerck
Lynda Grine
Debby Thomas
Dissertation
2023
Promising tools to facilitate the implementation of TDM of biologics in clinical practice
Rani Soenen
Christophe Stove
Alessio Capobianco
Hanne De Schutter
Marie Dobbelaere
Tahmina Mahjor
Merel Follens
Jo Lambert
Lynda Grine
A1
Journal Article
in
JOURNAL OF CLINICAL MEDICINE
2022
Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis
Rani Soenen
Zhigang Wang
Lynda Grine
Erwin Dreesen
Lisa Schots
Els Brouwers
Paul Declerck
Debby Thomas
Jo Lambert
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL DERMATOLOGY
2022
Effectiveness and tolerability of guselkumab in patients with psoriasis : a longitudinal Belgian retrospective multicenter study
Pierre-Dominique Ghislain
Valérie Failla
Jo Lambert
Rani Soenen
Lynda Grine
Julio Tannous
Françoise Guiot
Fabienne Willaert
Hugues Fierens
Mark Vandaele
et al.
A2
Journal Article
in
JAAD INTERNATIONAL
2021
Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis
Nathalie Van den Berghe
Aurélie Truffot
Miet Peeters
Griet Compernolle
Els Brouwers
Rani Soenen
Lynda Grine
Ann Gils
Maya Imbrechts
A1
Journal Article
in
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
2020
Real‐life effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis : a Belgian retrospective multicentre study
F. Benhadou
PD. Ghislain
F. Guiot
F. Willaert
V. Del Marmol
Jo Lambert
Rani Soenen
H. Fierens
M. de la Brassinne
A1
Journal Article
in
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
2020
Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy
Rani Soenen
Evelyn Meulewaeter
Lynda Grine
Nathalie Van den Berghe
Els Brouwers
Reinhart Speeckaert
Sven Lanssens
Linda Temmerman
Jo Lambert
Ann Gils
A1
Journal Article
in
JOURNAL OF INVESTIGATIVE DERMATOLOGY
2019
Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy
Rani Soenen
Evelyn Meulewaeter
Lynda Grine
Linda Temmerman
Sven Lanssens
Els Brouwers
Nathalie Van den Berghe
Reinhart Speeckaert
Jo Lambert
Ann Gils
C3
Conference
2019
Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy
Rani Soenen
Evelyn Meulewaeter
Lynda Grine
Nathalie Van den Berghe
Els Brouwers
Reinhart Speeckaert
Sven Lanssens
Linda Temmerman
Jo Lambert
Ann Gils
C3
Conference
2018
Activities ( 0 )
Results
Impact narratives ( 0 )
Patents ( 0 )